Medical Information
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

MANNITOL Principal Display Panel (mannitol injection, USP)

PRINCIPAL DISPLAY PANEL - 50 mL Vial Label

50 mL Single-dose Fliptop Vial

25% MANNITOL
Injection, USP
12.5 g/50 mL (250 mg/mL)

For Intravenous Use Only.

WARNING: SEE INSERT REGARDING
CONTRAINDICATION IN SEVERE
RENAL IMPAIRMENT.

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

PRINCIPAL DISPLAY PANEL - 50 mL Vial Label

PRINCIPAL DISPLAY PANEL - 50 mL Vial Tray

50 mL Single-dose Fliptop Vial
25 Units/NDC 0409-4031-01

25% MANNITOL
Injection, USP
12.5 g/50 mL
(250 mg/mL)

Rx only

FOR INTRAVENOUS USE ONLY

Hospira

PRINCIPAL DISPLAY PANEL - 50 mL Vial Tray
Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

*9AM-5PM ET Monday to Friday; excluding holidays.

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: (800) 438-1985

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch